|
KMID : 0624620120450090489
|
|
BMB Reports
2012 Volume.45 No. 9 p.489 ~ p.495
|
|
|
AMP-activated protein kinase: implications on ischemic diseases
|
|
Ahn Yong-Joo
Kim Hwe-Won
Lim Hee-Jin
Lee Max
Kang Yu-Hyun
Moon Sang-Jun
Kim Hyeon-Soo
Kim Hyung-Hwan
|
|
|
Abstract
|
|
|
|
Ischemia is a blockage of blood supply due to an embolism or a hemorrhage in a blood vessel. When an organ cannot receive oxygenated blood and can therefore no longer replenish its blood supply due to ischemia, stresses, such as the disruption of blood glucose homeostasis, hypoglycemia and hypoxia, activate the AMPK complex. LKB1 and CaMKKβ are essential activators of the AMPK signaling pathway. AMPK triggers proangiogenic effects through the eNOS protein in tissues with ischemic conditions, where cells are vulnerable to apoptosis, autophagy and necrosis. The AMPK complex acts to restore blood glucose levels and ATP levels back to homeostasis. This review will discuss AMPK, as well as its key activators (LKB1 and CaMKKβ), as a central energy regulator and evaluate the upstream and downstream regulating pathways of AMPK. We will also discuss how we can control this important enzyme inischemic conditions to prevent harmful effects in patients with vascular damage.
|
|
|
KEYWORD
|
|
|
AMPK, CaMKKβ, Ischemia, LKB1
|
|
|
FullTexts / Linksout information
|
|
|
|
|
|
Listed journal information
|
|
  
|